NEW YORK – Twist Bioscience reported after the close of the market on Wednesday that revenues for its fiscal fourth quarter 2019 rose 87 percent year over year.
For the three months ended Sept. 30, 2019, the firm reported revenues of $15.7 million compared to $8.4 million in the year-ago period. It beat analysts' average revenue estimate of $14.1 million.